Scientists have developed a new experimental drug that aims to use the body’s immune system in a response against cancer, which is now entering early phase clinical trials. The experimental drug has been developed by Cancer Research UK scientists and targets suppressive ‘regulatory’ immune cells inside a tumour, significantly improving long-term survival in animal models [ ]
The post Next-generation immunotherapy against cancer enters clinical trials appeared first on Health Europa.
Tuesday 26 January 2021
healtheuropa - 3 month ago
Next-generation immunotherapy against cancer enters clinical trials
Latest News
